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Abstract
Background: Phospholipase D (PLD) catalyzes conversion of phosphatidylcholine into choline and phosphatidic acid,
leading to a variety of intracellular signal transduction events. Two classical PLDs, PLD1 and PLD2, contain
phosphatidylinositide-binding PX and PH domains and two conserved His-x-Lys-(x)4-Asp (HKD) motifs, which are critical
for PLD activity. PLD4 officially belongs to the PLD family, because it possesses two HKD motifs. However, it lacks PX and PH
domains and has a putative transmembrane domain instead. Nevertheless, little is known regarding expression, structure,
and function of PLD4.
Methodology/Principal Findings: PLD4 was analyzed in terms of expression, structure, and function. Expression was
analyzed in developing mouse brains and non-neuronal tissues using microarray, in situ hybridization, immunohistochem-
istry, and immunocytochemistry. Structure was evaluated using bioinformatics analysis of protein domains, biochemical
analyses of transmembrane property, and enzymatic deglycosylation. PLD activity was examined by choline release and
transphosphatidylation assays. Results demonstrated low to modest, but characteristic, PLD4 mRNA expression in a subset
of cells preferentially localized around white matter regions, including the corpus callosum and cerebellar white matter,
during the first postnatal week. These PLD4 mRNA-expressing cells were identified as Iba1-positive microglia. In non-
neuronal tissues, PLD4 mRNA expression was widespread, but predominantly distributed in the spleen. Intense PLD4
expression was detected around the marginal zone of the splenic red pulp, and splenic PLD4 protein recovered from
subcellular membrane fractions was highly N-glycosylated. PLD4 was heterologously expressed in cell lines and localized in
the endoplasmic reticulum and Golgi apparatus. Moreover, heterologously expressed PLD4 proteins did not exhibit PLD
enzymatic activity.
Conclusions/Significance: Results showed that PLD4 is a non-PLD, HKD motif-carrying, transmembrane glycoprotein
localized in the endoplasmic reticulum and Golgi apparatus. The spatiotemporally restricted expression patterns suggested
that PLD4 might play a role in common function(s) among microglia during early postnatal brain development and splenic
marginal zone cells.
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Introduction
Phospholipase D (PLD) is an important phospholipid signaling
enzyme, which catalyzes conversion of phosphatidylcholine (PC)
into choline and phosphatidic acid (PA) following activation by
diverse cellular signaling molecules, such as hormones, growth
factors, and neurotransmitters [1,2,3]. PA is, in turn, converted
into two second messengers, diacylglycerol (a protein kinase C
activator) and lysophosphatidic acid (LPA) (ligand for G-protein-
coupled LPA receptors; see [4]), which are involved in regulation
of membrane and vesicle trafficking, cell proliferation, migration,
and actin cytoskeleton dynamics [1,5,6,7]. PA has been implicated
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in diverse cellular functions due to activity with target proteins [8].
In the brain, PLD also plays a pivotal role in neuronal
proliferation and survival, neurite outgrowth, and neurodegener-
ation [9,10,11]. There are two distinct genes in mammals, PLD1
and PLD2 [12,13,14,15]. In the N-terminal region, PLD1 and
PLD2 proteins contain Phox homology (PX) and pleckstrin
homology (PH) domains, both of which are involved in membrane
targeting of PLD [16,17,18,19], which leads to membrane
localization and activation of PLD. In the C-terminal region,
PLD1 and PLD2 contain two conserved His-x-Lys-x-x-x-x-Asp
sequences (where x is any amino acid) and are designated HKD
motifs; these are essential for PLD enzymatic activity [20]. In
addition to the enzymatically, well-characterized, classical PLDs
(PLD1 and PLD2), a bioinformatic homology search for the HKD
motif identified a superfamily of PLD-like HKD motif-containing
proteins. This superfamily consists of eight protein classes,
including bacterial cardiolipin synthase (CLS), phosphatidylserine
synthase (PSS) and endonuclease (Nuc), and Vaccinia virus p37K
and K4L [21]. Human Hu-K4 [22,23] and mouse SAM9 [24],
which are now officially designated ‘‘PLD family member 3
(PLD3)’’, lack PX and PH domains and exhibit no PLD activity,
despite two HKD motifs [23,24]. There are three additional PLD
family members: ‘‘PLD family member 4 (PLD4)’’, ‘‘PLD family
member 5 (PLD5)’’, and ‘‘PLD family member 6 (PLD6)’’.
However, little is known about these non-classical PLDs, which
have a putative TM domain instead of PX and PH domains.
The present study identified a developmentally regulated
transcript, PLD4, after searching the cerebellar development
transcriptome database (CDT-DB) for characteristic spatiotempo-
ral gene expression patterns during mouse cerebellar development
[25]. The basic properties of PLD4 have not been reported, but
these findings identified unique features of PLD4 in the amino acid
sequence, as well as functions and expression, compared with
other members of the PLD superfamily.
Results
Amino acid sequence comparison of mouse PLD4 with
PLD superfamily members
By analyzing gene expression profiles of CDT-DB during
postnatal mouse cerebellar development, a developmentally regu-
lated transcript was identified (CDT-DB ID number CD00130;
DDBJ/GenBank/EMBL accession number BP426385). Subse-
quent cloning and sequencing analysis identified this mRNA
transcript as PLD4 (Fig. S1). PLD4 is an official member of the
PLD family of enzymes. This family is composed of six members
(PLD1–6), all of which contain a PLD-phosphodiesterase (PDE)
domain (PLD-PDE) consisting of a conserved HKD motif
(Fig. 1A). In the C-terminal region, PLD family members (with
the exception of PLD6) possess two PDE domains, PLD-PDE1
and PLD-PDE2, which contain HKD – HKD1 and HKD2 –
respectively (Fig. 1B). HKD motifs are critical for PLD activity
[20] and are involved in forming the active site of phosphate
binding, as shown by crystal structural analyses of Salmonella Nuc
[26] and Streptomyces PLD [27] (shown as StNuc and SspPLD in
Fig. 1B, respectively). In the N-terminal region, classical PLDs
(PLD1 and PLD2) with PLD activity contain PX and PH
domains; these proteins will hereafter be referred to as PXPH-
type PLDs [12,13,15,17,20,28]. PLD1 and PLD2 share 45%
identity in overall amino acid sequences. However, the non-
classical PLD (PLD3–6) contains a putative transmembrane (TM)
domain in place of PX and PH domains. In the present study,
PLD3 and PLD4 were analyzed, which we will refer to as TM-
type PLDs, because PLD5 contains less conserved sequences in
the HKD motifs, and PLD6 has only a single HKD motif. The
TM-PLDs PLD3 and PLD4 exhibited only 28% identity between
the amino-acid sequences. However, PLD3 and PLD4 exhibited
the greatest homology in the PLD-PDE1 and PLD-PDE2
domains, which are also highly homologous with the Vaccinia
virus K4L PLD-like protein (66.7% and 53.8% identity,
respectively), compared with PXPH-PLDs (14.8% and 15.4%
identity, respectively) and other superfamily members (Fig. 1B).
In addition to the lack of PX and PH domains, TM-PLDs likely
possess altered amino-acid sequences in the critical domains that
correspond to the PXPH-PLD phosphate-binding structure.
PLD4 mRNA expression is prominent during the first
postnatal week in the mouse cerebellum and exhibits
greatest expression in the mouse spleen
Temporal expression analysis by GeneChip microarrays
revealed low levels of PLD4 mRNA expression during postnatal
development of the mouse cerebellum (Fig. 2). This was confirmed
by semi-quantitative RT-PCR (Fig. S2A). PLD4 mRNA expres-
sion gradually increased after birth, peaked at P7, and was
significantly reduced thereafter (Fig. S2A,B). These results
suggested a role for PLD4 in early cerebellar development. Within
the PLD family, another TM-PLD – PLD3 – exhibited the highest
mRNA expression levels during the postnatal stage; expression
peaked around the first postnatal week and then gradually
declined with age (Fig. 2A). Among the PXPH-PLDs, expression
of PLD1 mRNA was low and gradually decreased after birth,
whereas PLD2 expression was greater and peaked at P7 before
decreasing thereafter (Fig. 2A).
Expression patterns of PLD4 mRNA in eight different tissues
(brain, heart, kidney, liver, lung, spleen, testis, and thymus) of P7
and P21 mice were determined with GeneChip microarrays
(Fig. 3). Among the tissues tested, signal values for PLD4 mRNA
were very low in the brain at P7 and P21 compared with PLD3
mRNA. The highest level was observed in the spleen, and
moderate levels were detected in the liver, lung, and thymus at P7,
as well as in the lung and thymus at P21. In contrast, PLD3
mRNA expression was greatest in the brain, followed by the
thymus. However, it should be noted that in the spleen (at P7 and
P21) and liver (at P7), PLD4 and PLD3 levels were comparable,
and these levels were greater than PLD1 and PLD2.
PLD4 mRNA expression is restricted to a subset of cells
located within the white matter region during the early
postnatal stage
Cellular expression of PLD4 mRNA in P7 and P21 mouse brain
sections was analyzed by in situ hybridization (ISH) (Fig. 4). At P7,
PLD4 mRNA signals were weak (Fig. 4A-a), but modestly
localized, in a subset of cells located in the white matter of
cerebellar lobules, but not in the deep cerebellar nuclei (DCN)
region (Fig. 4B-a and a’). These signals were also observed in a
subset of cells located in a subregion of the corpus callosum (CC)
and near the subventricular zone (SVZ) (Fig. 4B-d and d’). PLD4
mRNA expression was distinguishable from myelin basic protein
(MBP) mRNA expression in oligodendrocytes clustered within the
cerebellar white matter (Fig. 4B-b and b’) and CC (Fig. 4B-e and
e’). PLD4 mRNA expression was also distinguishable from glial
fibrillary acidic protein (GFAP) mRNA expression in astrocytes
(Fig. 4B-c, c’, d and d’), neural stem cells, and radial glia in the
SVZ (Fig. 4-d and d’). At P21, detectable signals for PLD4 mRNA
were not identified in any brain regions using these methods
(Fig. 4A-b). These results demonstrated that PLD4 mRNA is
expressed in cell type(s) preferentially localized around white
Phospholipase D4
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matter and throughout brain regions during the early postnatal
period.
PLD4 is expressed in white matter microglial cells in early
postnatal mouse brains and is predominantly localized in
cells within the red pulp of mouse spleens
To identify cell types that express PLD4 mRNA, double
labeling was performed by ISH and immunohistochemistry (IHC),
respectively, on cerebellar sections of P7 mice (Fig. 5). ISH signals
of PLD4 mRNA were localized to the cerebellar white matter
region and did not merge with IHC signals for GFAP or MBP
(Fig. 5A). This was consistent with data obtained from ISH, as
presented in Fig. 4. Interestingly, PLD4 ISH signals in the
cerebellar white matter closely matched IHC signals for Iba1 (a
microglial marker) [29] (as shown in the rightmost panels of
Fig. 5A–C). Some PLD4 mRNA-expressing cells were also
Figure 1. Structural comparisons of PLD superfamily members. A, protein structures and domains of mouse PLD family members PLD1,
PLD2, PLD3, PLD4 (CDT-DB ID =CD00130), PLD5, and PLD6. Top line represents amino acid (aa) position. PX, Phox homology domain; PH, pleckstrin
homology domain; PLD-PDE1 and PLD-PDE2, PLD-phosphodiesterase domain 1 and 2, respectively; TM, transmembrane domain. B, amino-acid
sequence alignment of the PLD-PDE domains containing conserved HKD motifs of PLD superfamily members. mPLD1–6, PLD1–6 of mice; VvK4L, K4L
protein of Vaccinia virus; EcCLS, cardiolipin synthase of Escherichia coli; EcPSS, phosphatidylserine syntase of E. coli; SspPLD, PLD of Streptomyces sp.
strain PMF; StNuc, nuclease of Salmonella typhimurium IncN plasmid; CaNuc, nuclease of Clostoridium acetobtylicum. The amino-acid sequences of
two PDE domains (PDE1 and PDE2) containing the conserved His-x-Lys-x-x-x-x-D (where x is any amino acid) motif (HKD1–2, motif 1 and motif 2,
respectively) are aligned. PDE1 and PDE2 domain sequences are surrounded by a frame. Conserved His (H), Lys (K), and Asp (D) residues are
highlighted black. mPLD6, StNuc, and CaNuc contain only one HKD motif and the HKD-containing sequences are aligned with PDE1-HKD1 domains
from other members. Conserved amino acid residues from the superfamily are in bold. Conserved hydrophobic patches in mPLD1 and mPLD2 are
highlighted grey. Conserved amino acid residues of mPLD3, mPLD4, and VvK4L are underlined.
doi:10.1371/journal.pone.0013932.g001
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scattered within layer II–III of the cerebral cortex, the stratum-
lacunosum-moleculare (sl-m) of the hippocampal CA1, and the
inferior colliculus; these cells also expressed Iba1 protein, but not
GFAP (Fig. 5B and C). These results demonstrated that PLD4
mRNA was expressed in microglial cells in early postnatal mouse
brains.
The mouse spleen expressed the highest levels of PLD4 mRNA
among the different tissues tested, as shown in Figure 3. Although
it was difficult to detect reliable PLD4 expression in mouse brains
using these conventional methods, PLD4 expression was detected
within the red pulp of the mouse spleen and was largely localized
in cells around the marginal zone (Fig. 6A).
PLD4 is a transmembrane glycoprotein located in
intracellular organelles
Mouse PLD4 protein, deduced from the cDNA sequence,
comprises 503 amino acid residues (calculated molecular mass,
56,154 Da), which contain a putative TM domain (amino acid
position [aa] 37–57) (Fig. 1A). However, western blot analysis
indicated that protein lysates of COS7 cells transfected with the
pcDNA-PLD4 expression vector exhibited a strongly immunore-
active broad band between 50 and 70 kDa (Fig. 6B). Bioinfor-
matics analysis of the predicted PLD4 amino-acid sequence
suggested the presence of eight consensus sites of Asn-linked
glycosylation (aa 89, 148, 169, 247, 279, 415, 425, and 442) in the
C-terminal region, which was downstream of the TM domain (Fig.
S1). Therefore, to determine the possibility of glycosylation, PLD4
proteins from mouse spleen were analyzed by enzymatic
deglycosylation (because of difficulty with analyzing trace amounts
of endogenous PLD4 protein expressed in the cerebellum). In the
membrane fraction, but not the soluble fraction, there was strong
immunoreactivity for PLD4 at approximately 70 kDa (Fig. 6C).
Upon peptide:N-glycosidase (PNGase) F treatment, the major
immunoreactive band was shortened to approximately 46 kDa
(Fig. 6C). Site-specific mutagenesis of eight Asn-linked glycan
consensus sites (Asn to Gln mutations) suggested that PLD4 was
exogenously expressed in HEK293 cells and contained large N-
glycosylated moieties at multiple consensus sites (Fig. S5B). These
results demonstrated that PLD4 is a highly N-glycosylated
transmembrane protein.
To examine intracellular localization of PLD4, the EGFP-fused
PLD4 construct was transfected into four different cell lines
(HEK293, COS7, MDCK, and HeLa), and cellular images of
EGFP fluorescence were analyzed. EGFP fluorescence formed a
meshwork-like structure in the peripheral region of the nucleus in
HEK293 cells (Fig. 7A). Similar meshwork-like localization
patterns were also observed in COS7 and MDCK cells (data not
shown). Double immunostaining for PLD4 and subcellular
markers was performed in HeLa cells transfected with pcDNA3-
PLD4 (Fig. 7B, C). PLD4 immunoreactivity was co-localized with
Figure 2. Temporal profiles of mouse PLD1–4 mRNA expres-
sion during the postnatal period. Expression profiles of PLD1–4
(Pld1, CD07009; Pld2, CD04198; Pld3, CD03550; Pld4, CD08836 in the
CDT-DB) mRNAs in mouse cerebella at E18, P7, P14, P21, and P56 were
analyzed using GeneChip microarrays (Affymetrix MG 430 2.0 Array).
Average values of normalized hybridization signals are presented. Error
bars show standard error of the mean (SEM) from four independent
experiments.
doi:10.1371/journal.pone.0013932.g002
Figure 3. Tissue distribution of mouse PLD1–4 mRNA expression. Expression profiles of PLD1–4 (Pld1, CD07009; Pld2, CD04198; Pld3,
CD03550; Pld4, CD08836 in the CDT-DB) mRNAs in the brain, heart, kidney, liver, lung, spleen, testis, and thymus tissues of C57BL6/J mice at P7 (A)
and P21 (B) were analyzed using GeneChip microarrays (Affymetrix MG 430A 2.0 Array). Average values of normalized hybridization signals are
indicated (mean 6 SEM, n = 3).
doi:10.1371/journal.pone.0013932.g003
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calnexin, an endoplasmic reticulum (ER) resident protein (Fig. 7B),
and PLD4 expression also formed a clustered pattern with golgin
97, a trans-Golgi network protein (Fig. 7C). These results suggested
that PLD4 protein was localized in organelle membranes,
including the ER and Golgi complex.
PLD4 does not exhibit authentic PLD enzymatic activity
As shown in Figure 1B, comparative alignment of the HKD
motif amino acid sequence, which is essential for PLD enzymatic
activity, demonstrated the presence of several differences between
TM-PLDs and the PXPH-PLDs (see Discussion). Therefore, PLD
activity was examined in mouse PLD4 proteins, which were
exogenously expressed in HEK293 cells, by analyzing choline
release and transphosphatidylation activities in the presence or
absence of GTPcS (mammalian PLD1 is activated by G proteins
[2]). Protein lysates of cells transfected with PLD2 (positive control)
exhibited high [3H]choline release activity at pH 7.4 (Fig. 8A) and
retained a weak, but significant, level of activity at pH 5.2 (Fig. 8B),
regardless of the presence or absence of GTPcS. However, cell
lysates transfected with PLD4 did not exhibit significant PLD
activity, such as cells transfected with vector alone. Finally,
transphosphatidylation activity of PLD was analyzed using 1-
butanol as the nucleophile to generate [3H]phosphatidylbutanol
(PBut). Protein lysates of PLD4-expressing cells did not form a
Figure 4. Spatial cellular profiles of PLD4 mRNA expression in mouse brains as determined by in situ hybridization. A, distribution of
PLD4 mRNA in sagittal sections of mouse brains at P7 (a) and P21 (b). Scale bars = 1 mm. B, images of cerebellum (panels a–c and a’–c’) and cerebral
cortex (panels d–f and d’–f’) expressing PLD4, MBP, and GFAP mRNAs at P7. Regions of mRNA signals in panels a–f are magnified in panels a’–f’,
respectively. Cb, cerebellum; CC, corpus callosum; Cx, cerebral cortex; DCN, deep cerebellar nuclei; EGL, external granular layer; Hi, hippocampus; IGL,
internal granular layer; LV, lateral ventricle; ML, molecular layer; Ob, olfactory bulb; Po, pons; SVZ, subventricular zone; WM, white matter. Scale
bars = 500 mm in a; 100 mm in a’, d and d’.
doi:10.1371/journal.pone.0013932.g004
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Figure 5. Mouse PLD4 mRNA expression is localized in white matter microglia of early postnatal brains. A, Double labeling analysis of
mouse cerebellar sections using in situ hybridization (ISH) of PLD4 mRNA and immunohistochemistry (IHC) with glial cell marker proteins. PLD4 mRNA
(dark blue color) and protein (brown color) for GFAP (astrocyte marker) (left panel), MBP (oligodendrocyte marker) (middle panel), or Iba1 (microglia
marker) (right panel) are simultaneously detected around the white matter region of the mouse cerebellum at P7. Panels a, b, and c show enlarged
Phospholipase D4
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significant amount of [3H]PBut, compared with PLD2-expressing
cells (Fig. 8C). These results suggested that PLD4 does not exhibit
authentic PLD activity, although deglycosylated PLD4 might
possess PLD activity.
Discussion
The present study identified the characteristic mRNA expres-
sion profile of PLD4 during mouse brain development. Results
demonstrated that PLD4 is a transmembrane protein containing
Asn-linked glycans and it is intracellularly localized to organelle
membranes, such as the ER and Golgi. PLD4 expression in
HEK293 cells did not exhibit authentic PLD enzymatic activity. In
addition, results demonstrated that PLD4 was not a classical PLD
(PLD1 or PLD2), and PLD4 might play a role as an organellar
membrane-associated protein in a subset of Iba1-positive microg-
lial cells spatiotemporally enriched in the white matter of early
postnatal mouse brains, as well as in splenic marginal zone cells.
Previous studies reported that PLD1 and PLD2 mRNAs
[13,14,15,30], as well as PLD3 mRNA [23,24], are highly
expressed in various brain regions and in many non-neuronal
tissues. In contrast, temporal and cellular expression patterns of
PLD4 mRNA are fairly restricted to developing mouse brains and
various tissues. This expression was particularly marked in a small
cell population of the white matter layer in cerebellar lobules, as
well as in the CC near the SVZ, during the first postnatal week.
Some expressing cells were also scattered in the cerebral cortical
layer, the sl-m of the hippocampal CA1, and the inferior colliculus.
These PLD4 mRNA-positive cells were identified as Iba1-positive
microglia, which likely corresponded to a subset of microglia that
transiently appeared in white matter of developing brains
[31,32,33,34]. It was recently demonstrated that PLD4 expression
in microglial cells exhibits an extracellular stimulus-dependent
response (Ohtani, Yamaguchi, and Baba, manuscript in prepara-
tion). Among the non-neuronal tissues tested, PLD4 mRNA levels
were greatest in the spleen, and intense PLD4 expression was
detected around the splenic marginal zone, where macrophages
are located [35].
PLD4 contains eight Asn-linked glycosylation consensus sites
within the C-terminal region (Fig. S1). The present study
demonstrated that exogenously expressed PLD4 was an integral
membrane protein carrying the Asn-linked glycan moiety; PLD4
was localized in a meshwork-like ER structure and in the Golgi
(possibly in the nuclear membrane as well), although it was difficult
to localize endogenous PLD4 in neuronal cells using the present
methods. These results suggested that PLD4 as a type-2
transmembrane glycoprotein within organellar membranes. It
contained a short N-terminus region that faces the cytoplasm and
Figure 6. PLD4 protein expression and glycosylation. A, Mouse PLD4 protein expression is observed in cells within the red pulp, and largely
around the marginal zone, of adult spleens. Immunohistochemical labeling of adult mouse spleen sections with anti-PLD4 antibody. PLD4
immunolabels are largely detected in splenic marginal zone cells within the red pulp. MZ, marginal zone; RP, red pulp; WP, white pulp. Scale
bars = 500 mm. B, Western blot analysis of PLD4 proteins exogenously expressed in COS7 cells using an anti-PLD4 antibody. PLD4 and vector
represent protein lysates of cells transfected with pcDNA3-PLD4 and pcDNA3 vector alone, respectively. C, Deglycosylation of endogenous PLD4
proteins in the mouse spleen membrane fraction by N-glycosidase-F (PNGase) digestion. Input, protein samples before treatment; +PNGase and -
PNGase, treated with and without PNGase, respectively. The major immunoreactive bands of approximately 45,46 kDa and 66,76 kDa after
treatment with and without PNGase, respectively, are indicated with arrows. Left, sizes in kDa of molecular weight markers.
doi:10.1371/journal.pone.0013932.g006
images of the frame indicated in the top panels. B and C, double labeling of layer II–III in the cerebral cortex, the stratum-lacunosum-moleculare (sl-
m) of the hippocampal CA1 region, inferior colliculus, and cerebellar white matter by ISH for PLD4 mRNA and IHC (green) for Iba1 or GFAP.
Conventional NBT/BCIP chromagen detection (dark blue) in B and HNPP/Fast Red fluorescent detection (red) in C were used. ISH signals for PLD4
mRNA are merged with IHC signals for Iba1 protein in these brain regions. WM, white matter; IGL, internal granular layer; ML, molecular layer. Scale
bars = 100 mm and 50 mm in top and bottom of panel A, respectively; 20 mm in B and 10 mm in C.
doi:10.1371/journal.pone.0013932.g005
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a long C-terminal putative catalytic domain containing HKD
motifs, which reside within the lumen. It has been shown that
human PLD3 (also known as Hu-K4) protein is exogenously
expressed in COS7 cells and is also a glycosylated type-2
transmembrane protein in the ER [23].
Considering transmembrane topology, TM-PLDs might exert
activity against substrates or targets within the organelle (luminal
side), but not on the cytoplasmic side. However, membrane-
associated PXPH-PLDs catalyze cytoplasm-facing substrates in the
plasma membrane and intracellular compartments, including the
ER, endosomes, and secretory granules (Cockcroft, 2001). The
present results demonstrated that protein lysates of PLD4-
transfected HEK293 cells exhibited no obvious PLD activity,
even at pH 5.2, which was similar to acidity conditions within
secretory granules (,pH 5.5) or the Golgi lumen (,pH 6.2 or 7.4,
which is identical to near neutral pH of the cytoplasm and ER
lumen) [36,37]. However, it remains to be determined whether
PLD4 exhibits enzymatic activity and whether the deglycosylated
form of PLD4 possesses PLD activity.
Two HKD motifs (HKD1 and HKD2) are conserved in the
PLD superfamily, with the exception of PLD6 and Nuc; these
HKD motifs are critical for PLD activity in PXPH-PLDs [20].
Crystal structural analyses of Salmonella Nuc (StNuc) [26] and
Streptomyces PLD (SspPLD) [27] (Fig. 1B) have revealed that HKD
motifs and the flanking sequences form a phosphate-binding site.
Taking into account previous results of the structure-function
relationship between HKD motifs and PLD activity, the following
structural features of TM-PLDs, which were distinguishable from
PXPH-PLDs, will be discussed. First, three hydrophobic amino-
acid patches (highlighted with grey in Fig. 1B), which are located
within the phosphate-binding tertiary structure, according to
SspPLD data [27], are important for catalytic activity, as well as
for the inter-domain association between HKD1 and HKD2 in
the rat PLD1 [28]. In contrast, TM-PLDs (and also K4L) contain
the aromatic amino acids Phe (F), Trp (W), and Tyr (Y) in
corresponding sequences (Fig. 1B). Second, Gly-Gly (GG) and
Gly-Ser (GS) motifs, which are located seven residues downstream
of HKD1 and HKD2, respectively, are well-conserved among the
PXPH-PLDs. A mutation of N-terminal GG to GS increases
transphosphatidylation activity in Streptoverticillium cinnamoneum
PLD (ScPLD) [38]. Interestingly, TM-PLDs and K4L contain
GS at the N-terminal end, although the present data demonstrated
Figure 7. Intracellular localization of PLD4 protein exogenously expressed in cultured cell lines. A, EGFP fluorescent imaging (green) and
DAPI nuclear staining (blue) of HEK293 cells transfected with pEGFP-PLD4. PLD4 is localized in a meshwork-like structure and around the periphery of
nuclei. B and C, immunocytochemical localization of PLD4 protein (green) and either calnexin, an ER marker (red) (B) or golgin 97, a trans-Golgi
marker (red) (C), in HeLa cells transfected with pcDNA3-PLD4. PLD4 is colocalized with calnexin in the ER and with golgin 97 in the Golgi complex.
Scale bars = 10 mm.
doi:10.1371/journal.pone.0013932.g007
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that PLD4 exhibited no significant transphosphatidylation activity
(Fig. 8C). In the C-terminal GS motif, it has been shown that the
Ser residue contributes to thermal enzymatic stability in ScPLD
[38], and a mutation that changes GS to GT results in reduced
enzymatic activity to 39% of human PLD1 levels [20]. The C-
terminal motif in TM-PLDs and K4L is GT, instead of GS
(Fig. 1B), which might be related to the loss of PLD activity in
these family members. Third, tertiary structure analysis of StNuc
demonstrates that the Glu (E) residue 29 residues downstream of
the first HKD2 amino acid is involved in forming the active site
(Struckey and Dixon, 1999) (Fig. 1B). Family members with
enzymatic activity, including PXPH-PLDs, E. coli CLS, and PSS,
contain either Glu (E) or Asp (D) downstream of HKD2, although
this residue is a Tyr (Y) in SspPLD (Fig. 1B). However, in TM-
PLDs and K4L, Glu (E) is located opposite of 29 residues
downstream of HKD1, but not HKD2. The structural differences
in the catalytic active site between TM-PLDs and PXPH-PLDs
might be associated with enzymatic properties, such as substrate
specificity.
In conclusion, these results suggested that PLD4 is a HKD
motif-containing protein family member that lacks authentic PLD
activity, which is most likely due to structural alterations in PX/
PH domains and HKD motifs critical for enzymatic activity.
Moreover, the unique spatiotemporal expression profiles of PLD4
suggest a role in cell function(s), which are common between early
postnatal white matter microglia and splenic marginal zone cells,
including macrophages.
Materials and Methods
Animals
Mice (ICR and C57BL/6J) and rabbits (New Zealand White)
were purchased from Nihon SLC (Hamamatsu, Japan). All animal
studies were conducted according to recommendations and
protocols approved by the Animal Care and Use Committee of
RIKEN (approval number: H21-2-244(4)) and the Tokyo
University of Pharmacy and Life Sciences (approval number:
Y09–15). Animals were housed in an environment with 12:12-
Figure 8. PLD activity assay of PLD4 expression in HEK293 cells. A–B, [3H]choline release activity in HEK293 cells transfected with PLD4, PLD2,
or pcDNA3 vector alone (Vec) or non-transfected cells (2), in the presence or absence of GTPcS at pH 7.4 (A) or pH 5.2 (B). The inset in A shows the
same data for vector (Vec)-transfected and PLD4-transfected cells on a different scale. Data from two independent experiments (#1 and#2, n = 3) are
shown for PLD4 and Vec. C, Transphosphatidylation activity of HEK293 cells transfected with PLD4, PLD2, or vector alone (Vec), or non-transfected
cells (2), in the presence or absence of GTPcS. The right graph shows the same data for Vec, PLD4, and – on a different scale.
doi:10.1371/journal.pone.0013932.g008
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hour light/dark cycle (daytime 8:00–20:00), controlled tempera-
ture (2362uC) and humidity (55610%), and ad libitum access to
food and water.
Cloning and plasmid construction of PLD cDNAs
The first clone (clone ID number CD00130 see CDT-DB
[www.cdtdb.brain.riken.jp]; DDBJ/GenBank/EMBL accession
number BP426385) was isolated by fluorescent differential display
analysis of the mouse cerebellar transcriptome during postnatal
developmental stages, as previously described [25]. Full-length
PLD4 cDNAs were cloned by screening full-length cDNA
libraries. The cDNA libraries were generated from poly(A)+
mRNAs isolated from mouse cerebella at P7 using the oligo-
capping method for sequence homology to clone CD00130 as
previously described [39]. The full-length cDNA sequence was
determined using the dideoxynucleotide termination method with
a DNA sequencer (ABI 3730xl, Applied Biosystems, Foster City,
CA). Mouse PLD2 cDNA was similarly cloned by RT-PCR and
was used following sequence verification. PLD4 and PLD2 cDNA
were cloned into the mammalian expression vector pcDNA3
(Invitrogen, Rockville, MD). For enzymatic activity analysis, the
mouse PLD2 expression vector pcGN-mPLD2 [14], which was
kindly provided by Dr. M. Frohman, was utilized.
Reverse-transcription polymerase chain reaction (RT-PCR)
cDNAs were prepared from total RNAs obtained from mouse
cerebella (ICR) at embryonic day (E)18 and at postnatal days (P)0,
P3, P7, P12, P21, and P56. PCRs were performed with 25 or 28
cycles in a thermocycler (GeneAmp PCR system 9700, ABI) as
previously described [25,39]. Forward and reverse primers for
amplification of each gene were: PLD4, 59-GACTGGAGTTCC-
CACTATGCTAT-39 and 59-AGGTGGCAGGGTTTTATTG-
TGGCT-39, respectively; glyceraldehyde-3-phosphate dehydroge-
nase (GAPDH), 59-GCCATCAACGACCCCTTCATTGACC-
TC-39 and 59-GCCATGTAGGCCATGAGGTCCACCAC-39,
respectively. GAPDH was utilized as a constant signal standard.
GeneChip analysis
RNA preparation and GeneChip reactions were performed as
previously described [25]. Gene expression profiles during
cerebellar development of C57BL/6J mice (E18, P7, P14, P21,
and P56) were analyzed using the GeneChip system Affymetrix
Mouse Genome 430 2.0 Array (GE Healthcare UK, Buckingham-
shire, England), which included probes for approximately 39,000
transcripts. Tissue distribution of gene expression was analyzed in
eight different mouse tissues (brain, thymus, lung, heart, liver,
spleen, kidney, and testis) (C57BL/6J) at P7 or P21 using the
Affymetrix Mouse Genome 430A 2.0 Array (GE Healthcare),
which included probes for approximately 15,000 transcripts. Data
were normalized and analyzed using GeneSpring GX software
(Agilent Technologies, Santa Clara, CA) as previously described
[25].
In situ hybridization
Brain in situ hybridization (ISH) was performed as previously
described [25,39]. The template sequences were used to generate
riboprobes as follows: PLD4 (GenBank NM_178911), 153-bp
fragment amplified with 59-primer AGGGCTGAGGGTT-
GATCC (nucleotide position [nt] 1613–1630) and 39-primer CT-
GCCGGAAGCTGTTTGT (nt 1748–1765); MBP (NM_
001025259), 162-bp fragment amplified with 59-primer TCG-
CCACAATAACGTGAG (nt 1774–1791) and 39-primer TGC-
TTCTGTCCAGCCATACT (nt 1976–1935); GFAP (NM_
010277), 400-bp fragment amplified with 59-primer CACGAAC-
GAGTCCCTAGA (nt 908–907) and 39-primer TCACATCAC-
CACGTCCTT (nt 1290–1307). Sections (6- or 8-mm thick) from
4% paraformaldehyde-fixed, paraffin-embedded, P7 and P21
mouse brains (ICR) were deparaffinized and treated with a
proteinase K solution (10 ng/ml in PBS; Invitrogen, Carlsbad, CA,
USA) at room temperature for 15 min. Following acetylation, the
sections were incubated in hybridization buffer containing 1 mg/
ml digoxigenin-labeled riboprobes at 60uC overnight in a
humidified chamber. In addition to PLD4 riboprobes produced
from PCR amplicon as a template, hybridization in Fig. 5B–C was
performed using 2 mg/ml of alkaline-hydrolyzed PLD4 riboprobe
which was prepared from 1.5-kb full-length PLD4 cDNA as a
template by in vitro transcription. Hybridized sections were washed
by successive immersion in 26 SSC, 50% formamide (60uC for
20 min, twice), TNE (1 mM EDTA, 0.5 M NaCl, 10 mM Tris-
HCl, pH 8.0, at 37uC for 10 min), TNE containing 20 ng/ml
RNase A (37uC for 30 min), 26 SSC (room temperature for
10 min, twice), and 0.26 SSC (60uC for 30 min, twice).
Hybridization signals were detected using a digoxigenin detection
kit (Roche Diagnostics) and examined using microscopes (SMZ-U
and Eclipse E800; Nikon, Tokyo, Japan) equipped with a cooled
CCD camera (Spot; Diagnostic Instruments, Sterling Heights,
MI). Digital images were processed using Adobe Photoshop 6.0
software.
Antibodies
The antigenic synthetic peptide of mouse PLD4 consisted of C-
terminal 16 amino acid residues (from amino acid 488 to 503,
YAMDLDRQVPSQDCVW) with no homology to the C-termini
of the other mouse PLD family members (Fig. S3). Female, New
Zealand, white rabbits (Nihon-SLC) were immunized by subcu-
taneous injection of peptide conjugated to keyhole limpet
hemocyanin (catalog number [Cat.] H7017, Sigma-Aldrich, St.
Louis, MO). The resultant PLD4 antibody (FD130-1#4) was
purified by affinity chromatography on an antigenic peptide-
coupled SulfoLink column (SulfoLink Immobilization Kit for
Peptides, product #44999, Pierce, Rockford, IL) and utilized at a
concentration of 1 mg/ml. Specificity of the anti-PLD4 antibody
was verified by a pre-absorption test with the antigenic peptide
(Fig. S4C), as well as by specific recognition of expressed
recombinant proteins and similarity in developmental and tissue
distribution patterns between immunoreactive protein (Fig. S4B)
and mRNA (Fig. S2). Other primary antibodies used were goat
polyclonal anti-calnexin antibody (1:1000) (Cat. sc-6465, Santa
Cruz Biotechnology, Santa Cruz, CA), mouse monoclonal anti-
golgin-97 antibody (1:1000) (A-21270, Invitrogen), rabbit poly-
clonal anti-ionized calcium-binding adaptor molecule 1 (Iba1)
antibody (1:400) (Cat. 019-19741, Wako Pure Chemical Indus-
tries, Osaka, Japan), rabbit polyclonal anti-glial fibrillary acidic
protein (GFAP) antibody (1:10) (Cat. N1506, Dako, Glostrup,
Denmark), and rat monoclonal anti-myelin basic protein (MBP)
antibody (1:100) (Cat. MAD386, Chemicon/Millipore, Temecula,
CA). The secondary antibody for western blot analyses was
horseradish peroxidase (HRP)-conjugated anti-rabbit IgG (H+L)
(1:2000) (Cat. NA9340, GE Healthcare UK Ltd.). The secondary
antibodies applied to immunocytochemical analyses were Alexa
Fluor 488-conjugated anti-rabbit IgG (1:2000) (Cat. A11029,
Invitrogen), Alexa Fluor 594-conjugated anti-goat IgG (1:2000)
(Cat. A11058, Invitrogen), and Alexa Fluor 594-conjugated anti-
mouse IgG (1:2000) (Cat. A11005, Invitrogen). The secondary
antibodies used for immunohistochemical analyses were biotiny-
lated anti-rabbit IgG (Cat. PK-4001) and anti-rat IgG (Cat. PK -
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4004) (1:250) from the Vectastain ABC kit (Vector Laboratories,
Burlingame, CA, USA).
Subcellular fractionation
Spleens were dissected from mice (ICR) under deep diethyl
ether anesthesia and were homogenized in an ice-cold Teflon-glass
potter homogenizer containing 9 vol (w/v%) homogenizing buffer
(0.25 M sucrose, 5 mM Tris-HCl, pH 7.4) and protease inhibitor
cocktail (1 mM phenylmethylsulfonyl fluoride, 10 mM pepstatin A,
10 mM leupeptin) as previously described [39]. The homogenates
were centrifuged at 10006g for 10 min at 4uC to obtain precipitate
fraction 1 (ppt1). The supernatants were then centrifuged at
105,0006g for 1 h at 4uC to obtain precipitate fractions 2+3
(ppt2+3), and the cytosolic fraction was obtained from the
supernatant. Ppt1 and ppt2+3 were re-suspended in suspension
buffer (20 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1 mM DTT,
and protease inhibitor cocktail), and protein concentrations were
measured using a BCA protein assay kit (Pierce, Rockford, IL).
Western blot analysis
Protein lysates were separated by SDS-polyacrylamide gel
electrophoresis and were electro-blotted onto nitrocellulose filter
membranes (Hybond-ECL, Cat. RPN2020D, GE Healthcare UK)
as previously described [39]. The blots were incubated at room
temperature for 1 h in blocking buffer consisting of 5% (w/v) skim
milk (Snow Brand, Sapporo, Japan) and 16PBS containing 0.1%
(v/v) Tween 20 (PBS-T). Blots were then incubated with primary
antibody in PBS-T for 1 h, followed by HRP-conjugated
secondary antibody for 1 h. After washing with PBS-T, the bound
antibody was detected using ECL Plus western blotting detection
reagent (Cat. RPN2106, GE Healthcare UK Ltd.), and images
captured on X-ray film (MXJB Film, Cat. 864-8651, Eastman
Kodak, Rochester, NY).
Enzymatic deglycosylation
The deglycosylation reaction was performed as previously
described [39]. Briefly, protein samples were pre-incubated in
1% SDS, 144 mM 2-mercaptoethanol, and protease inhibitor
cocktail at 37uC for 30 min. Asn-linked glycans were removed by
treatment with 30 U/ml N-glycosidase F (PNGase, from Flavobac-
terium meningosepticum) (Roche Diagnostics, Mannheim, Germany)
in 20 mM sodium phosphate buffer (pH 7.2), 0.5% NP40, 20 mM
EDTA, 1 mM 2-mercaptoethanol, and protease inhibitor cocktail
overnight at 37uC.
Cell culture and transfection
HeLa, COS7, MDCK, and HEK293 cell lines were obtained
from the Cell Bank of RIKEN Bioresource Center (Tsukuba,
Japan) and were cultured in DMEM in a humidified atmosphere
with 5% CO2 at 37uC. Transfection was performed using
Lipofectamine 2000 reagent (Invitrogen) as previously described
[39].
Immunocytochemistry
Cultured cells were rinsed with PBS, fixed with 4% PFA/PBS at
room temperature for 15 min, rinsed three times in PBS, and then
permeabilized in 0.2% Triton X-100 in PBS for 5 min. After
blocking with 5% normal donkey serum (Cat. D9663, Sigma-
Aldrich) in PBS at room temperature for 1 h, the cells were
incubated with anti-PLD4 antibody at 4uC overnight, rinsed in
PBS, and then incubated with Alexa Fluor-conjugated secondary
antibody in PBS at room temperature for 1 h before being rinsed
again in PBS. Immunostained sections were mounted using
Vectashield mounting medium (Vector Laboratories, Burlingame,
CA) and were examined using a confocal laser microscope (LSM
510 META; Carl Zeiss, Oberkochen, Germany). Digital images
were processed using Adobe Photoshop 6.0 software.
Immunohistochemistry and double labeling by in situ
hybridization and immunohistochemistry
Immunohistochemistry (IHC) of frozen sections prepared from
mouse spleens was performed as previously described [39].
C57BL/6J mice (Nihon SLC) were anesthetized with diethyl
ether and transcardially perfused with PBS, followed by 4%
PFA/PBS. The spleens were dissected, post-fixed in 4% PFA at
4uC for 1 h, and cryoprotected by immersion in 20% sucrose in
PBS overnight at 4uC. After embedding in Tissue-Tek OCT
compound (Sakura Finetechnical, Tokyo, Japan), the spleens
were frozen in dry-ice powder and cut into 10–16-mm thick
sagittal sections at 218uC using a cryostat (CM1850; Leica
Microsystems, Wetzlar, Germany). The sections were then air-
dried for 1 h, rinsed three times in PBS, and incubated with
methanol at 220uC for 20 min, followed by three washes with
PBS at 4uC for 10 min each. After blocking with 10% normal
donkey serum (Cat. D9663, Sigma-Aldrich) in 0.2% Triton X-
100 and PBS, the sections were incubated with anti-PLD4
antibody at 4uC overnight. Sections were then rinsed in 0.2%
Triton X-100 in PBS and allowed to react with biotin-
conjugated anti-rabbit IgG (1:1000) in 5% normal serum,
0.2% Triton X-100, and PBS at room temperature for 1 h.
The immunostaining was detected using a Vectastain ABC kit
(0.05% diaminobenzidine [DAB]/0.01% H2O2). Images were
captured using a microscope (Nikon Eclipse800, or Olympus
BX51) equipped with a cooled CCD camera (SPOT; Diagnostic
Instruments, Sterling Heights, MI, or ProgRes C14; Jepoptik,
Munich, Germany). For double staining of mRNAs and proteins
in mouse brain paraffin sections (P7 old, 6-mm thick), following
ISH, IHC was performed, as shown in Fig. 5A, 5B and 5C. In
Fig. 5A, sections subjected to ISH with the PLD4 PCR amplicon
probes were boiled in citrate buffer (pH 6.0) for 1 min in a
microwave oven for heat-induced antigen retrieval. The sections
were blocked for 1 hr in 10 mM PBS/0.3% Triton X-100/10%
goat serum (PBS-TGS), and then incubated overnight at 4uC
with primary antibodies diluted in PBS-TGS. After rinsing in
PBS, the sections were incubated with ABC complex (Vectastain
ABC kit) for 30 min at RT, and immunoreactions were
visualized using H2O2 in 3,39-diaminobentidine/50 mM Tris
buffer for 10 min at RT. Images were captured using a light
microscope (Axio Scope Imaging System; Carl Zeiss, Oberko-
chen, Germany). In Fig. 5B, following NBT/BCIP staining of
ISH with 2 mg/ml of alkaline-hydrolyzed full-length PLD4
riboprobe, sections were incubated with either anti-Iba1
(1:250) or anti-GFAP antibody (1:5) at room temperature for
1 hr, followed by biotinylated anti-rabbit IgG at room temper-
ature for 1 hr, and Vectastain ABC kit (0.5 mg/ml DAB/0.01%
H2O2). For double fluorescent by ISH and IHC staining
(Fig. 5C), the ISH reaction was first performed using alkaline-
hydrolyzed full-length PLD4 riboprobe as described above.
Subsequently, the sections were incubated with alkaline phos-
phatase-labeled anti-DIG antibody (1:1000) together with either
anti-Iba1 or anti-GFAP antibody at 4uC overnight, followed byh
Alexa 488-labeled anti-rabbit IgG (1:1000) at room temperature
for 1 hr, and HNPP Fluorescent Detection set (Roche #11 758
888 011). Fluorescent digital images were acquired using a
confocal laser-scanning microscope LSM510 (Carl Zeiss). Digital
images were processed using Adobe Photoshop software.
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Assay of phospholipase D activity
PLD activity was determined by measuring the generation of
3H-labeled choline from [choline-methyl-3H]dipalmitoyl-PC
(NEN Life Science Products, Boston, MA) (phosphohydrolase
activity) and 3H-labeled phosphatidyl butanol (PBut) (transpho-
sphatidylation activity) as previously described [40,41]. Briefly, the
HEK293 cells were transfected with either pcDNA3-PLD4 or
pcDNA3-PLD2, and were then suspended in ice-cold lysis buffer
[20 mM HEPES, pH 7.4, 1 mM EGTA, 1 mM MgCl2, 1 mM
dithiothreitol, 1 mM phenylmethylsulfonyl fluoride, 20 mg/ml (L-
3-trans-carboxyoxirane-2-carbonyl)-L-leucyl-agmatine, E-64] and
lysed by sonication. Lysates were used for the PLD activity assay
following removal of unbroken cells by centrifugation at 1,0006g
for 5 min. Twenty microliters of lipid vesicles, which contained
phoshpatidylethanolamine (PE), phosphatidylinositol 4,5-bispho-
sphate (PIP2), and PC at a molar ratio of 16:1.4:1 with [choline-
methyl-3H]dipalmitoyl-PC (total 46105 cpm/assay), was added to
100 ml mixture containing a PLD source, 50 mM HEPES-NaOH
(pH 7.4 or pH 5.6), 3 mM EGTA, 80 mM KCl, 2.5 mM MgCl2,
and 2 mM CaCl2. The reaction was performed at 37uC for 1 h in
the presence or absence of 5 mM GTPcS. Radioactivity of
[3H]choline, which was released from [choline-methyl-3H]dipal-
mitoyl-PC, was measured.
To assess PLD transphosphatidylation, mixed lipid vesicles (PE/
PIP2/PC, 16:1.4:1 mM) containing [2-palmitoyl-9,10-
3H]dipalmi-
toyl-PC (NEN Life Science Products) to yield 46105 cpm/assay
were prepared. A total of 20 ml lipid vesicle was added to 10 ml cell
lysate in a total volume of 120 ml containing 50 mM HEPES-
NaOH (pH 7.4), 3 mM EGTA, 80 mM KCl, 2.5 mM MgCl2,
1.2 mM CaCl2, and 0.3% 1-butanol. The reaction was incubated
at 37uC for 1 h in the presence or absence of 5 mM GTPcS. After
extraction of cellular lipids, [3H]PBut was separated by TLC on
silica gel LK6D plates (Whatman, Maidstone, UK) using a solvent
system of upper-phase ethyl acetate/2,2,4-trimethylpentane/acetic
acid/water (13:2:3:10 by volume). The amount of [3H]PBut
formed was expressed as a percentage of total radioactivity
recovered from the TLC plate.
Bioinformatics analysis
Amino acid sequence data were obtained from NCBI. Protein
domain predictions were referred from Protein Knowledgebase
UniProtKB. The PLD4 mRNA expression in mouse brains and
non-neuronal tissues were analyzed by using transcriptome
database CDT-DB.
Supporting Information
Figure S1 Amino acid sequence and putative protein domains of
mouse PLD4. The transmembrane (TM, solid horizontal bar), two
PLD-PDE domains (PDE1 and PDE2, rectangles), two HKD
motifs (HKD1 and HKD2, grey horizontal bars), and eight Asn-
linked glycosylation consensus sites (Asn-89, 148, 169, 247, 279,
415, 425 and 442 with asterisks) are indicated. Asn-397 is marked
with an open circle. The Asn residues are mutated to Qln, as
shown in Figure S5. Conserved amino acids in the HKD motifs
are shown in bold.
Found at: doi:10.1371/journal.pone.0013932.s001 (0.46 MB
TIF)
Figure S2 Developmental time series expression patterns of
PLD4 mRNA during postnatal development of the mouse
cerebellum. A, Semi-quantitative RT-PCR analyses at E18, P0,
P3, P7, P12, P15, P21, and P56. Two representative results of
PLD4 mRNA expression at cycle number 25 and 28, and
GAPDH (control) at cycle 25. B, Relative values (%) of PLD4
GeneChip data are shown in A (peak value at P7 is defined as
100%). GeneChip data shown in Figure 2, which shows peak
expression of PLD4 mRNA at P7, is verified by these results.
Found at: doi:10.1371/journal.pone.0013932.s002 (0.33 MB TIF)
Figure S3 C-terminal amino acid sequences of six mouse PLD
family members and the antigen sequence used for generation of
the anti-PLD4 antibody. The C-terminal amino acid sequences of
six mouse PLD family members (PLD1,6) are aligned. There is
no homology between these C-terminal sequences, except for
significant homology between PLD1 and PLD2 (colons indicate
identical amino acids). The C-terminal 16 amino acids (highlight-
ed black) of PLD4 were used as the antigenic peptide to generate
anti-mouse PLD4 antibody.
Found at: doi:10.1371/journal.pone.0013932.s003 (0.18 MB TIF)
Figure S4 Immunodetection of PLD4 protein by anti-PLD4
antibody. A and B, Subcellular protein fractions (ppt1, ppt2+3,
and sup3) prepared from mouse cerebellum (at P1, P7, P14, and
P21) and spleen (at P7, 7 week [w], and 17w) were immunoblotted
with anti-PLD4 antibody. By employing this conventional method
(see Materials and Methods), the antibody specifically reacted with
a broad 66,76-kDa band in the ppt2+3 spleen fraction (B),
whereas detected only a trace amount of PLD4 in the cerebellum
(A). PLD4 protein levels between spleen and cerebellum are
consistent with PLD4 mRNA levels indicated by GeneChip
analyses shown in Fig. 3. C, Antigen absorption assay of anti-
PLD4 antibody. The ppt2+3 protein fractions prepared from the
mouse spleen at 7w were immunoblotted with anti-PLD4 antibody
in the presence or absence of antigenic peptide (7 mg/ml) at 4uC
overnight. The antigen blocked immunodetection, indicating
specificity of the anti-PLD4 antibody to the antigenic amino acid
sequence.
Found at: doi:10.1371/journal.pone.0013932.s004 (0.45 MB TIF)
Figure S5 Analyses of glycosylated PLD4 by enzymatic
deglycosylation and site-specific mutagenesis. A, Deglycosylation
of endogenous PLD4 in the mouse spleen with N-glycosidase-F
(PNGase), as shown in Figure 6B. Non-specific bands are indicated
by asterisks. B, Site-specific mutagenesis of eight Asn-linked glycan
consensus sites in PLD4. Consensus Asn residues (N) at 89, 148,
169, 247, 279, 415, 425, and 442 were individually substituted by
Gln (Q). Mutated PLD4, except for N425 and N442Q, exhibits
slightly faster mobility than wild-type PLD4 (WT). However, the
non-consensus Asn-397 was mutated to Q (N397Q) as a control
and exhibits similar mobility as WT. These results suggest that
exogenously expressed PLD4 has large and complex glycan
moieties and at least six consensus Asn residues at 89, 148, 169,
247, 279, and 415. However, the in vivo glycosylation sites of PLD4
protein remain to be shown.
Found at: doi:10.1371/journal.pone.0013932.s005 (0.27 MB TIF)
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